Today, Marseille Immunopôle and their experts and platforms provide an outstanding multidisciplinary scientific environment for thoracic immuno-oncology research.
Oncologist by training, I joined the team headed by Prof Barlesi, within which my activity is shared between care in the Multidisciplinary Oncology and Therapeutic Innovations Department at Hôpital Nord and the Marseille Oncology Early Testing Center at Hôpital de La Timone, and teaching and research at Aix-Marseille University. My special interest is translational research in thoracic oncology, particularly in the field of biomarkers, and I have the benefit of international experience in the subject.
One of the greatest therapeutic innovations in the care of bronchial carcinoma is immunotherapy, which increases the chances of survival and provides greater tolerability than chemotherapy. Nevertheless, our experience with these drugs is limited and we still need to optimize these new treatments. In order to do this, I lead innovative research programs in thoracic immuno-oncology that should provide an improvement in the care of our patients. In this way, I make the most of my double status of clinician and researcher and take advantage of my daily experience at patients’ bedside.
This work mobilizes all the participants in health care and research: pulmonologists, surgeons, radiation therapists, anatomical pathologists, etc., and young residents, as well as molecular biologists, immunologists, biostatisticians, mathematicians, pharmacists, etc., and PhD students at research institutes.
Today, Marseille Immunopôle and their experts and platforms provide an outstanding multidisciplinary scientific environment for thoracic immuno-oncology research.#clinic
Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research.
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
AMU, AP-HM, CIML, INNATE PHARMA
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
CCI Marseille Provence
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.
AMU, IPC, CRCM